NO20024906L - Antitumorale ecteinascidinderivater - Google Patents

Antitumorale ecteinascidinderivater

Info

Publication number
NO20024906L
NO20024906L NO20024906A NO20024906A NO20024906L NO 20024906 L NO20024906 L NO 20024906L NO 20024906 A NO20024906 A NO 20024906A NO 20024906 A NO20024906 A NO 20024906A NO 20024906 L NO20024906 L NO 20024906L
Authority
NO
Norway
Prior art keywords
ecteinascidine
antitumoral
derivatives
ecteinascidine derivatives
antitumoral ecteinascidine
Prior art date
Application number
NO20024906A
Other languages
English (en)
Other versions
NO329125B1 (no
NO20024906D0 (no
Inventor
Maria Flores
Andres Francesch
Pilar Gallego
Jose Luis Chicharro
Maria Zarzuelo
Carolina Fernandez
Ignacio Manzanares
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0009043A external-priority patent/GB0009043D0/en
Priority claimed from PCT/GB2000/001852 external-priority patent/WO2000069862A2/en
Priority claimed from GB0022644A external-priority patent/GB0022644D0/en
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of NO20024906D0 publication Critical patent/NO20024906D0/no
Publication of NO20024906L publication Critical patent/NO20024906L/no
Publication of NO329125B1 publication Critical patent/NO329125B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20024906A 2000-04-12 2002-10-11 Ecteinascidinderivater, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene eventuelt i kombinasjon med andre legemidler ved fremstilling av farmsoytiske preparater for behandling av tumorer NO329125B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0009043A GB0009043D0 (en) 2000-04-12 2000-04-12 New autitumoural derivatives of ET-743
PCT/GB2000/001852 WO2000069862A2 (en) 1999-05-14 2000-05-15 Hemisynthetic method and intermediates thereof
GB0022644A GB0022644D0 (en) 2000-09-14 2000-09-14 Antitumoral derivatives of ET-743
PCT/GB2001/001667 WO2001077115A1 (en) 2000-04-12 2001-04-12 Antitumoral ecteinascidin derivatives

Publications (3)

Publication Number Publication Date
NO20024906D0 NO20024906D0 (no) 2002-10-11
NO20024906L true NO20024906L (no) 2002-11-27
NO329125B1 NO329125B1 (no) 2010-08-30

Family

ID=26244092

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024906A NO329125B1 (no) 2000-04-12 2002-10-11 Ecteinascidinderivater, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene eventuelt i kombinasjon med andre legemidler ved fremstilling av farmsoytiske preparater for behandling av tumorer

Country Status (27)

Country Link
US (1) US7202361B2 (no)
EP (1) EP1280809B1 (no)
JP (1) JP5219323B2 (no)
KR (1) KR100886496B1 (no)
CN (1) CN1436191B (no)
AR (1) AR032879A1 (no)
AT (1) ATE299146T1 (no)
AU (1) AU784249C (no)
BG (1) BG65987B1 (no)
BR (1) BRPI0110024B8 (no)
CA (1) CA2406080C (no)
CZ (1) CZ304749B6 (no)
DE (1) DE60111845T2 (no)
DK (1) DK1280809T3 (no)
EA (1) EA006206B1 (no)
ES (1) ES2244598T3 (no)
HK (1) HK1049005B (no)
HU (1) HU230918B1 (no)
IL (1) IL152094A (no)
MX (1) MXPA02010088A (no)
NO (1) NO329125B1 (no)
NZ (1) NZ521550A (no)
PL (1) PL210703B1 (no)
PT (1) PT1280809E (no)
SI (1) SI1280809T1 (no)
SK (1) SK288017B6 (no)
WO (1) WO2001077115A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0101960A3 (en) * 1998-05-11 2003-03-28 Pharma Mar Sa Metabolites of ecteinascidin 743, their use and pharmaceutical compositions containing them
MY164077A (en) 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
MY130271A (en) 1999-05-14 2007-06-29 Pharma Mar Sa Hemisynthetic method and new compounds
US7919493B2 (en) 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
US7420051B2 (en) 2000-05-15 2008-09-02 Pharma Mar, S.A. Synthetic process for the manufacture of an ecteinaschidin compound
MXPA02011319A (es) 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
GB0117402D0 (en) 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
BR0213424A (pt) * 2001-10-19 2004-12-14 Pharma Mar Sa Uso aperfeiçoado de composto antitumoral na terapia contra câncer
JP4208469B2 (ja) * 2002-01-29 2009-01-14 独立行政法人科学技術振興機構 エクテナサイジン類の全合成方法、エクテナサイジン類に類縁構造を持つ前記全合成用中間体化合物類、及び該中間体化合物類の合成方法
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
JP2007511499A (ja) 2003-11-13 2007-05-10 ファーマ・マール・エス・アー・ウー コンビネーション
AU2005288696A1 (en) * 2004-09-28 2006-04-06 Pharma Mar S.A., Sociedad Unipersonal Ecteinascidin compounds as anti -inflammatory agents
ATE368461T1 (de) 2004-10-29 2007-08-15 Pharma Mar Sa Zusammensetzungen enthaltend ecteinascidin und einen disaccharide
US8067462B2 (en) * 2004-12-20 2011-11-29 The Trustees Of Columbia University In The City Of New York Processes of making sesquiterpenoid tashironin, its analogs and their uses
US20090131498A1 (en) * 2005-01-18 2009-05-21 Danishefsky Samuel J Enantioselective Synthesis of Merrilactone and Its Analogs
GB0522082D0 (en) 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
WO2007087220A2 (en) * 2006-01-25 2007-08-02 The Trustees Of Columbia University In The City Of New York The total synthesis of ecteinascidin 743 and derivatives thereof
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
JP6037337B2 (ja) 2010-05-25 2016-12-07 ファルマ、マール、ソシエダード、アノニマPharma Mrs,S.A. エクチナサイジン化合物の製造のための合成方法
HUE049389T2 (hu) 2010-11-12 2020-09-28 Pharma Mar Sa Kombinált terápia topoizomeráz inhibitorral
JOP20190254A1 (ar) * 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN112679513B (zh) * 2019-10-18 2023-08-25 南通诺泰生物医药技术有限公司 一种制备曲贝替定的关键中间体的方法
CN114940682A (zh) * 2022-05-18 2022-08-26 博瑞制药(苏州)有限公司 芦比替定的晶型及其制备方法和用途
CN115677728A (zh) * 2022-11-02 2023-02-03 成都科岭源医药技术有限公司 一种海鞘素类化合物中间体的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59225189A (ja) 1983-06-03 1984-12-18 Shionogi & Co Ltd キノナミン誘導体およびその製造法
JPS6084288A (ja) 1983-10-13 1985-05-13 Shionogi & Co Ltd シアノキノナミンアセテ−ト類およびその製造法
ATE69234T1 (de) 1986-06-09 1991-11-15 Univ Illinois Ekteinascidine 729, 743, 745, 759a, 759b and 770.
US5256663A (en) * 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5089273A (en) * 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5149804A (en) 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
US5721365A (en) * 1989-09-15 1998-02-24 Us Health N-substituted piperazine NONOates
US5478932A (en) * 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds
US5985876A (en) * 1997-04-15 1999-11-16 Univ Illinois Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
HUP0101960A3 (en) * 1998-05-11 2003-03-28 Pharma Mar Sa Metabolites of ecteinascidin 743, their use and pharmaceutical compositions containing them
US6124292A (en) * 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
MY130271A (en) 1999-05-14 2007-06-29 Pharma Mar Sa Hemisynthetic method and new compounds
WO2001053299A1 (en) * 2000-01-19 2001-07-26 The Trustees Of Columbia University In The City Of New York Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.

Also Published As

Publication number Publication date
CZ20023352A3 (cs) 2003-05-14
WO2001077115A1 (en) 2001-10-18
PL357574A1 (en) 2004-07-26
NO329125B1 (no) 2010-08-30
BRPI0110024B8 (pt) 2021-05-25
EA200201083A1 (ru) 2003-04-24
EP1280809A1 (en) 2003-02-05
IL152094A (en) 2011-10-31
CA2406080A1 (en) 2001-10-18
PL210703B1 (pl) 2012-02-29
IL152094A0 (en) 2003-05-29
CN1436193A (zh) 2003-08-13
BG107220A (en) 2003-05-30
KR100886496B1 (ko) 2009-03-05
DE60111845T2 (de) 2006-04-27
HU230918B1 (hu) 2019-03-28
AR032879A1 (es) 2003-12-03
HUP0300534A3 (en) 2006-02-28
HK1049005B (zh) 2006-01-27
KR20030012864A (ko) 2003-02-12
US7202361B2 (en) 2007-04-10
CN1436191B (zh) 2011-09-14
BRPI0110024B1 (pt) 2019-07-16
MXPA02010088A (es) 2004-08-19
ES2244598T3 (es) 2005-12-16
SK288017B6 (sk) 2012-11-05
ATE299146T1 (de) 2005-07-15
NO20024906D0 (no) 2002-10-11
AU4672901A (en) 2001-10-23
CA2406080C (en) 2011-11-29
BG65987B1 (bg) 2010-08-31
JP2003530402A (ja) 2003-10-14
AU784249C (en) 2007-05-03
DK1280809T3 (da) 2005-11-07
JP5219323B2 (ja) 2013-06-26
BR0110024A (pt) 2003-02-18
EP1280809B1 (en) 2005-07-06
HUP0300534A2 (hu) 2003-07-28
EA006206B1 (ru) 2005-10-27
PT1280809E (pt) 2005-11-30
SK14352002A3 (sk) 2003-04-01
HK1049005A1 (en) 2003-04-25
US20030216397A1 (en) 2003-11-20
SI1280809T1 (sl) 2005-12-31
AU784249B2 (en) 2006-02-23
NZ521550A (en) 2004-10-29
CZ304749B6 (cs) 2014-09-24
DE60111845D1 (de) 2005-08-11

Similar Documents

Publication Publication Date Title
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
DE60121916D1 (de) Bohrloch-densitometer
DE60116273D1 (de) Tabakverarbeitung
NO20024130L (no) Brönnsirkulasjonssystem
NO20024906L (no) Antitumorale ecteinascidinderivater
NO20032246L (no) Örebeskyttelsesanordning
DE60134208D1 (de) Nkkommunikationsverfahren
ATE288437T1 (de) Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
DE60128645D1 (de) Rotor-Schaufelblatt-Zusammenbau
ATE298332T1 (de) Decahydro-isochinolinderivate
ATA2932001A (de) Schneefräse
DE60128494D1 (de) Wachstumhormonsekretionsförderer
DE50102988D1 (de) Bodenwischer
DE60103268D1 (de) Hochdruckumformspülanlage
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
PT1351959E (pt) Novos derivados de pleuromutilina
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es) Antitranspirantes
ATE280752T1 (de) Aminomethyl-phenyl-cyclohexanonderivate
DE10195909T1 (de) Viehfüttervorrichtung
NO20032862D0 (no) Benzoylpyridaziner
NO20024689D0 (no) Gelemballeringstape
ID28933A (id) Abrasif
AR027982A1 (es) Aril- y heteroarilsulfonatos
NO20010164D0 (no) Brönnhodeenhet

Legal Events

Date Code Title Description
MK1K Patent expired